Endogenous adenine mediates kidney injury in diabetic models and predicts diabetic kidney disease in patientsKumar Sharma, Loki Natarajan, Varun Sharma et al.|Journal of Clinical Investigation|2023Cited by 63
Glycolytic lactate in diabetic kidney diseaseManjula Darshi, Luxcia Kugathasan, Soumya Maity et al.|JCI Insight|2024Cited by 50
Efficacy, Mechanisms, and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Kidney Transplant RecipientsVikas S. Sridhar, Sunita Singh, Luxcia Kugathasan et al.|Clinical Journal of the American Society of Nephrology|2025Cited by 6
Effect of hyperglycemia and empagliflozin on markers of cardiorenal injury and inflammation in patients with type 1 diabetesLuxcia Kugathasan, David Z.I. Cherney, Vikas S. Sridhar et al.|Diabetes Research and Clinical Practice|2024Cited by 6
Mechanistic evaluation of ertugliflozin in patients with type 2 diabetes and heart failureYuliya Lytvyn, David Z.I. Cherney, Rosalie A. Scholtes et al.|Physiological Reports|2025Cited by 5